throbber

`
`EDITION
`
` Remington's
`
`ALFONSO R GENNARO
`Editor, and Chairman
`of the Editorial Board
`
`LUPIN EX. 1035
`
`Lupin v. iCeutica
`
`US Patent No. 8,999,387
`
`Page 1
`
`LUPIN EX. 1035
`Lupin v. iCeutica
`US Patent No. 8,999,387
`
`

`

`Pharmaceutical
`
`Sciences
`
`
`
`199o
`
`MACK PUBLISHING COMPANY
`
`Easton, Pennsylvania 18042
`
`Page 2
`
`Page 2
`
`

`

`of approximately one, according to others. Yet, the pene-
`tration of ethanol and dibromomethane are nearly equal,
`and other such enigmas exist.
`It is not surprising, then, that
`the effects of vehicles are not altogether predictable.
`A general statement might be made that if a drug is quite
`soluble in a poorly absorbed vehicle, the vehicle will retard
`the movement of the drug into the skin. For example, sali-
`cylic acid is 100 times as permeant when absorbed from
`water than from polyethylene glycol and pentanol is 5 times
`as permeant from water as from olive oil. Yet, ethanol
`penetrates 5 times faster from olive oil than from either
`water or ethanol, all of which denies the trustworthiness of
`generalizations about vehicles.
`‘
`Since the 1960s, there has been much interest in certain
`highly dielectric aprotic solvents, especially dimethyl sulfox-
`ide (DMSO). Such substances generally prove to be excel-
`lent solvents for both water- and lipid-soluble compounds
`and for some compounds not soluble in either water or lipid
`solvents. The extraordinary solvent properties probably
`are due to a high polarizability and van der Waals bonding
`
`“adjuvant” is not an adjuvant but rather it is only a nonde-
`terrent.
`Other Factors—A number of other less-well-defined fac-
`tors affect the absorption of drugs, some of which may oper-
`ate, in part, through factors already cited above. Disease or
`injury has a considerable effect upon absorption. For exam-
`ple, debridement of the stratum corneum increases the per-
`meability to topical agents, meriingitis increases the perme-
`ability of the blood—brain barrier, biliary insufficiency de-
`creases the absorption of lipid-soluble substances from the
`intestine and acid—base disturbances can affect the absorp-
`tion of weak acids or bases. Certain drugs, such as ouabain,
`that affect active transport processesmay interfere with the
`absorption of certain other drugs. The condition of the
`ground substance, or “intracellular cement,” probably bears
`on the absorption of certain types of molecules. Hyaluroni-
`dase, which depolymerizes the mucopolysaccharide ground
`substance, can be demonstrated to facilitate the absorption
`of some, but not all, drugs from subcutaneous sites.
`
`Drug Disposition
`
`‘The term drug disposition is used here to include all
`proc_esses_ which tend to lower the plasma concentration of
`drug,‘as opposed to drug absorption, which elevates the
`plasma level. Consequently, the distribution of drugs to the
`various tissues will be considered under Disposition. Some
`authors use the term disposition synonymously with elimi-
`nation, that is, to include only those processes which de-
`crease the amount of drug in the body.
`In the present
`Cfimtext, disposition comprises three categories of processes:
`distribution, biotransformation and excretion.
`
`Distribution, Biotransformation and Excretion
`
`It denotes the
`, _=T1_19 term distribution is self-explanatory.
`Dfirtitioning of a drug among the numerous locations where a
`df‘-lg may be contained within the body. Biotransforma-
`twns are the alterations in the chemical structure of a drug
`Phat are imposed upon it by the life processes. Excretion is,
`m,-359.1186, the converse of absorption, namely, the transpor-
`t".‘t19n Of the drug, or its products, out of the body. The term
`ggpliils Whether or not special organs of excretion are in-
`qve .
`.
`
`Distribution
`
`C’O‘E11;:b0dy may be considered to comprise a number of
`rtments: enteric (gastrointestinal), plasma, intersti-
`tial
`stmjaczrebrospinal fluid, bile, glandular secretions, urine,
`0 this Vesicles, cytoplasm or intracellular space, etc. Some
`Orp
`9 C0Inpartments,” such as urine and secretions, are
`0:2?“-ded, but since their contents relate to those in the
`cl
`Compartments, they also must be included.
`
`At first thought, it may seem that if a drug were distribut-
`ed passively (ie, by simple diffusion) and the plasma concen-
`tration could be maintained at a steady level, the concentra-
`tion of a drug in the water in all compartments ought to
`become equal.
`It is true that some substances, such as
`ethanol and antipyrine, are distributed nearly equally
`throughout the body water, but they are more the exception
`than the rule. Such substances are mainly small, un-
`charged, nondissociable, highly water-soluble molecules.
`The condition of small size and high water solubility al-
`lows for passage through the pores without the necessity of
`carrier or active transport. Small size also places a limit on
`van der Waals binding energy and configurational comple-
`mentariness, so that binding to proteins in plasma, or cells, is
`slight. The presence of a charge on a drug molecule makes
`for unequal distribution across charged membranes, in ac-
`cordance with the Donnan distribution (see below). Disso-
`ciability causes unequal distribution when there is a pH
`differential between compartments, as discussed under The
`pH Partition Principle (see below). Thus, even if a drug is
`distributed passively, its distribution may be uneven
`throughout the body. When active transport into, or a rapid
`metabolic destruction occurs within, some compartments,
`uneven distribution is also inevitable.
`The pH Partition Principle——-An important conse-
`quence of nonionic diffusion is that a difference in pH be-
`tween two compartments will have an important influence
`upon the partitioning of a weakly acidic or basic drug be-
`tween those compartments. The partition is such that the
`un-ionized form of the drug has the same concentration in
`both compartments, since it is the form that is freely diffus-
`ible; the ionized form in each compartment will have the
`
`
`
`Page 3
`
`

`

`
`
`pass through the lipid phase, as explained above for the
`morphinans and mecamylamine. Furthermore,
`ion-pair
`formation in carrier transport also bypasses nonionic diffu-
`sion. All processes that tend toward an equal distribution of
`drugs across membranes, and among compartments, will
`cause further deviations from theoretical predictions of pH
`partition.
`'
`Electrochemical and Donnan Distribution—-A drug
`ion may be distributed passively across a membrane in ac-
`cordance with the membrane potential, the charge on the
`drug ion and the Donnan effect. The relationship of the
`membrane potential to the passive distribution of ions is
`expressed quantitatively by the Nernst equation (Eq 7, page
`709) andalready has been discussed. Barring active trans-
`port, pH partition and binding, the drug will be said to be
`distributed according to the electrical gradient or to its
`“equilibrium” potential.
`If the membrane potential is 90
`mv, the concentration of a univalent cation will be 80 times
`as high within the cell as without; if the drug cation is
`divalent, the ratio will be 890. The distribution of anions
`would be just the reverse.
`If the membrane potential is but
`9 mv, the ratio for a univalent cation will be only 1.4 and for a
`divalent cation only 2.0.
`It, thus, can be seen how important
`membrane potential may be to the distribution of ionized
`drugs.
`a
`It was pointed out under Membrane Potentials, page 707,
`that large potentials derive from active transport of ions but
`that small potentials may result from Donnan distribution.
`Donnan membrane theory is discussed in Chapter 14.‘ Ac-
`cording to the theory, the ratio of the intracellular/extraceL
`lular concentration of a permeant univalent anion is equal to
`the ratio of extracellular/intracellular concentration of a
`permeant univalent cation. A more general mathematical
`expression that includes ions of any valence is
`
`At,
`
`1/Z,
`
`<A—> =<a>
`
`Ce
`
`1/Z,
`
`where A, is the intracellular and Ae the extracellular concen-
`tration of anion, Z, is the valence of cation, Z, is the valence
`of anion, C; is the intracellular and Ce the extracellular con-
`centration of cation and r is the Donnan factor. The value of
`r depends upon the average molecular weight and valence of
`the macromolecules (mostly protein) within the cell and the
`intracellular and extracellular volumes. Since the macro-
`molecules within the cell are charged negatively, the cation
`concentration will be higher within the cell,’ that is, C, > Ce.
`Since a Donnan distribution results in a membrane poten-
`tial, the distribution of drug ion also will be in keeping with
`the membrane potential.
`The Donnan distribution also applies to the distribution
`of a charged drug between the plasma and interstitial com-
`partment, because of the presence of anionic proteins in the
`plasma. Eq 8.applies by changing the subscript i to p, for
`plasma, and e to i, for interstitial. The Donnan factor, r, for
`plasma—interstitial space partition is about 1.05:1.
`Binding and Storage—Drugs frequently are bound to
`plasma proteins (especially albumin),
`interstitial sub-
`stances, intracellular constituents and bone and cartilage.
`If binding is extensive and firm, it will have a considerable
`impact upon the distribution, excretion and sojourn of the
`drug in the body. Obviously, a drug that is bound to a
`protein or any other macromolecule will not pass through
`the membrane in the bound form; only the unbound form
`can negotiate among the various compartments.
`The partition among compartments is determined by the
`binding capacity and binding constant in each compart-
`ment. As long as the binding capacity exceeds the quantity
`of drug in the compartment, the following equation general-
`ly applies:
`
`Page 4
`
`7 1 6
`
`CHAPTER 35
`
`concentration that is determined by the pH in that compart-
`ment, the pK and the concentration of the un-ionized form.
`The governing effect of pH and pK on the partition is known
`as the pH partition principle.
`To illustrate the principle, consider the partition of sali-
`cylic acid between the gastric juice and the interior of a
`gastric mucosal cell. Assume the pH of the gastric juice to
`be 1.0, which it occasionally becomes. The pK,, of salicylic
`acid is 3.0 (Martinm provides one source of pK values of
`drugs). With the Henderson—Hasselbach equation (see
`page 242) it may be calculated that the drug is only 1%
`ionized at pH 1.0.* The intracellular pH of most cells is
`about 7.0. Assuming the pH of the mucosal cell to be the
`same, it may be calculated that salicylic acid will be 99.99%
`ionized within the cells. Since the concentration of the un-
`ionized form is theoretically the same in both gastric juice
`and mucosal cells, it follows that the total concentration of
`the drug (ionized + un-ionized) within the mucosal cell will
`be 10,000 times greater than in gastric juice. This is illus-
`trated in Fig 35-11.
`‘ Such a relatively high intracellular
`concentration can have important osmotic and toxicologic
`consequences.
`
`Had the drug been a Weak base instead of an acid, the high
`concentration would have been in the gastric juice.
`In the
`small intestine, where the pH may range from 7.5 to 8.1, the
`partition of a weak acid or base will be the reverse of that in
`the stomach, but the concentration differential will be less,
`because the pH differential from lumen to mucosal cells, etc,
`will be less. The reversal of partition as the drug moves
`from the stomach to the small intestine accounts for the
`phenomenon that some drugs may be absorbed from one
`gastrointestinal segment and returned to another. The
`weak base, atropine, is absorbed from the small intestine,
`but, because of pH partition, it is “secreted” into the gastric
`Juice.
`
`The pH partition of drugs has never been demonstrated to
`be as marked as that illustrated in Fig 35-11 and in the text.
`Not only do many drug ions probably pass through the pores
`of the membrane to a significant extent, but also some may
`
`* The relationship of ionization and partition to pH and pK has been
`formulated in several different ways, but the student may calculate the
`concentrations from simple mass law equations. More sophisticated
`calculations and reviews of this subject are available.5»“'1"
`
`
`
`MUCOSAL CELL
`CYTOPLASM
`
`GASTRIC JUICE
`
`.
`
`pH 7.0
`
`"I133
`
`pH l.0
`
`, 1=[Un—ionized]v__ __ EUn-lonizedIl=1\
`
`2i
`
`99.99= Elonizedll
`
`it
`
`E Ionized] = 0.01
`
`nZ(
`
`17
`:u
`
`>2r
`
`n
`
`Fig 35-11. Hypothetical partition of salicylic acid between gastric
`juice and the cytoplasm of a gastric mucosal cell.
`It is assumed that
`the ionized form cannot pass through the cell membrane. The
`intragastric concentration of salicylic acid is arranged arbitrarily to
`provide unit concentration of the un-ionized form. Bracketed values:
`concentration; arrows:
`relative size depicts the direction in which
`dissociation-association is favored at equilibrium.
`
`Page 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket